EA Series Trust - MRBL Enhanced Equity ETF
EDGE
Get informed when a big investor buys or sells
+ FollowMarket Cap$41.86M
Close$
Share Statistics
| Market cap | $41.86 Million |
|---|---|
| Enterprise Value | $-1,190,724,533.00 |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 1.01% |
|---|---|
| Return on Assets | -0.41% |
| Return on Invested Capital | 228.54% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.15 |
| Enterprise Value to Net Income | 33 |
| Total Debt to Enterprise | -3.66 |
| Debt to Equity | -1.22 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About PDS Biotechnology Corporation
CEO: Frank Bedu-Addo Under normal circumstances, the fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities and derivative instruments that provide exposure to equity securities. To gain this exposu...